Joyisa Deb: Does Parenteral Iron Increase Infection Risk?
Joyisa Deb, Head Apollo Excelcare Hospital, shared a post on LinkedIn about the recent article she and her colleagues co-authored, adding:
“Happy to share that our review ‘Parenteral iron – Does it increase infection risk?’ is now published in Vox Sanguinis!
As intravenous (IV) iron becomes central to patient blood management (PBM), one question continues to generate debate:
Does parenteral iron increase infection risk?
My Key takeaway points are:
- Current evidence does not clearly show increased infection risk with IV iron, especially with newer formulations
- Clinical context influences infection risk (age, CKD/dialysis, iron load, ferritin, active infection)
- Careful, patient-specific individualised therapy remains essential
- How infection is defined in studies plays a crucial role in interpreting results
- The future lies in conducting robust RCTs with standardized infection outcomes and biomarker-guided, safer dosing strategies.
Grateful to all co – authors and collaborators!”
Title: Parenteral iron – Does it increase infection risk?
Authors: Joyisa Deb, Aswin K. Mohan, Suhasini Sil, Suvro Sankha Datta, Yoghini Nagandran, Manideepa Maji, Mohammad Kamrul Hassan Majumder, Saikat Mandal
Read the Full Article on Vox Sanguinis

Stay updated with Hemostasis Today.
-
May 24, 2026, 14:26Salome Mekhuzla: World Health Assembly Adopts Historic Global Resolution for Hemophilia and Bleeding Disorders
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke